The post Coinbase’s Base Delays Token Release for Decentralization appeared on BitcoinEthereumNews.com. Key Points: Base by Coinbase delays token release for ecosystem’s open-source growth. Focus on decentralization over quick token launch. Community feedback integral to Base’s strategic decisions. Base protocol, guided by Jesse Pollak at Coinbase, aims to evolve into an open-source ecosystem akin to Linux, prioritizing decentralization and cautious token issuance, Fortune reports. Coinbase’s strategy reflects a careful approach to align incentives with community goals, amidst growing blockchain ecosystems, without rushing to issue native tokens. Base’s Strategic Move Towards Long-Term Decentralization “Token issuance often comes at the expense of the broader community associated with the blockchain, enriching supporters. Therefore, Coinbase is proceeding with caution, determined not to rush the deployment of tokens and does not plan to announce a release date anytime soon.” — Jesse Pollak, Protocol Lead, Base (Coinbase) source. The implications of this delay are significant for both the cryptocurrency community and industry observers. By avoiding a rapid token launch, Coinbase aims to uphold democratic and sustainable token economy principles. This move may influence other blockchain projects to reassess their token strategies in pursuit of similar goals. Community feedback highlighted broad support, with developers and ecosystem participants expressing confidence in Base’s long-term vision. Industry experts, including Tom Schmidt of Dragonfly, acknowledged Jesse Pollak’s understanding of crypto principles, emphasizing that few in Coinbase share this deep expertise. Regulatory Considerations and Market Reactions Did you know? The concept of decentralization in blockchain technology is often compared to open-source software development, where community collaboration drives innovation. As of 07:25 UTC on October 3, 2025, according to CoinMarketCap, Ethereum (ETH) trades at $4,460.99, with a market cap of $538.46 billion, showing a 26.04% increase over the past 60 days. ETH remains crucial, serving as the settlement layer for transactions on Base. Ethereum(ETH), daily chart, screenshot on CoinMarketCap at 07:25 UTC on October 3,… The post Coinbase’s Base Delays Token Release for Decentralization appeared on BitcoinEthereumNews.com. Key Points: Base by Coinbase delays token release for ecosystem’s open-source growth. Focus on decentralization over quick token launch. Community feedback integral to Base’s strategic decisions. Base protocol, guided by Jesse Pollak at Coinbase, aims to evolve into an open-source ecosystem akin to Linux, prioritizing decentralization and cautious token issuance, Fortune reports. Coinbase’s strategy reflects a careful approach to align incentives with community goals, amidst growing blockchain ecosystems, without rushing to issue native tokens. Base’s Strategic Move Towards Long-Term Decentralization “Token issuance often comes at the expense of the broader community associated with the blockchain, enriching supporters. Therefore, Coinbase is proceeding with caution, determined not to rush the deployment of tokens and does not plan to announce a release date anytime soon.” — Jesse Pollak, Protocol Lead, Base (Coinbase) source. The implications of this delay are significant for both the cryptocurrency community and industry observers. By avoiding a rapid token launch, Coinbase aims to uphold democratic and sustainable token economy principles. This move may influence other blockchain projects to reassess their token strategies in pursuit of similar goals. Community feedback highlighted broad support, with developers and ecosystem participants expressing confidence in Base’s long-term vision. Industry experts, including Tom Schmidt of Dragonfly, acknowledged Jesse Pollak’s understanding of crypto principles, emphasizing that few in Coinbase share this deep expertise. Regulatory Considerations and Market Reactions Did you know? The concept of decentralization in blockchain technology is often compared to open-source software development, where community collaboration drives innovation. As of 07:25 UTC on October 3, 2025, according to CoinMarketCap, Ethereum (ETH) trades at $4,460.99, with a market cap of $538.46 billion, showing a 26.04% increase over the past 60 days. ETH remains crucial, serving as the settlement layer for transactions on Base. Ethereum(ETH), daily chart, screenshot on CoinMarketCap at 07:25 UTC on October 3,…

Coinbase’s Base Delays Token Release for Decentralization

Key Points:
  • Base by Coinbase delays token release for ecosystem’s open-source growth.
  • Focus on decentralization over quick token launch.
  • Community feedback integral to Base’s strategic decisions.

Base protocol, guided by Jesse Pollak at Coinbase, aims to evolve into an open-source ecosystem akin to Linux, prioritizing decentralization and cautious token issuance, Fortune reports.

Coinbase’s strategy reflects a careful approach to align incentives with community goals, amidst growing blockchain ecosystems, without rushing to issue native tokens.

Base’s Strategic Move Towards Long-Term Decentralization

“Token issuance often comes at the expense of the broader community associated with the blockchain, enriching supporters. Therefore, Coinbase is proceeding with caution, determined not to rush the deployment of tokens and does not plan to announce a release date anytime soon.” — Jesse Pollak, Protocol Lead, Base (Coinbase) source.

The implications of this delay are significant for both the cryptocurrency community and industry observers. By avoiding a rapid token launch, Coinbase aims to uphold democratic and sustainable token economy principles. This move may influence other blockchain projects to reassess their token strategies in pursuit of similar goals.

Community feedback highlighted broad support, with developers and ecosystem participants expressing confidence in Base’s long-term vision. Industry experts, including Tom Schmidt of Dragonfly, acknowledged Jesse Pollak’s understanding of crypto principles, emphasizing that few in Coinbase share this deep expertise.

Regulatory Considerations and Market Reactions

Did you know? The concept of decentralization in blockchain technology is often compared to open-source software development, where community collaboration drives innovation.

As of 07:25 UTC on October 3, 2025, according to CoinMarketCap, Ethereum (ETH) trades at $4,460.99, with a market cap of $538.46 billion, showing a 26.04% increase over the past 60 days. ETH remains crucial, serving as the settlement layer for transactions on Base.

Ethereum(ETH), daily chart, screenshot on CoinMarketCap at 07:25 UTC on October 3, 2025. Source: CoinMarketCap

Research analysis by the Coincu team identifies potential regulatory scrutiny as a factor for Base’s cautious strategy. Avoiding immediate financial upheaval demonstrates commitment to long-term stability, maintaining alignment with decentralization goals and minimizing volatility risks visible in past Layer 2 token launches. This is consistent with their assessment of the potential risks of market instability when new tokens are introduced too hastily.

Source: https://coincu.com/blockchain/base-delays-token-release-2025/

Piyasa Fırsatı
TokenFi Logosu
TokenFi Fiyatı(TOKEN)
$0.004697
$0.004697$0.004697
-4.57%
USD
TokenFi (TOKEN) Canlı Fiyat Grafiği
Sorumluluk Reddi: Bu sitede yeniden yayınlanan makaleler, halka açık platformlardan alınmıştır ve yalnızca bilgilendirme amaçlıdır. MEXC'nin görüşlerini yansıtmayabilir. Tüm hakları telif sahiplerine aittir. Herhangi bir içeriğin üçüncü taraf haklarını ihlal ettiğini düşünüyorsanız, kaldırılması için lütfen [email protected] ile iletişime geçin. MEXC, içeriğin doğruluğu, eksiksizliği veya güncelliği konusunda hiçbir garanti vermez ve sağlanan bilgilere dayalı olarak alınan herhangi bir eylemden sorumlu değildir. İçerik, finansal, yasal veya diğer profesyonel tavsiye niteliğinde değildir ve MEXC tarafından bir tavsiye veya onay olarak değerlendirilmemelidir.

Ayrıca Şunları da Beğenebilirsiniz

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

BullZilla, World Liberty Financial, MoonBull, La Culex, and Polkadot (DOT) are taking the spotlight among emerging and established crypto projects […] The post 5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale appeared first on Coindoo.
Paylaş
Coindoo2025/10/18 08:15
Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Paylaş
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Paylaş
BitcoinEthereumNews2025/09/18 05:26